nach oben

Obesity Surgery

Erschienen in:

01.02.2014 | Review Article

Controversy Surrounding ‘Mini’ Gastric Bypass

verfasst von: Kamal K. Mahawar, William R. J. Carr, Shlok Balupuri, Peter K. Small

Erschienen in: Obesity Surgery | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Mini gastric bypass is a modification of Mason loop gastric bypass with a longer lesser curvature-based pouch. Though it has been around for more than 15 years, its uptake by the bariatric community has been relatively slow, and the procedure has been mired in controversy right from its early days. Lately, there seems to be a surge in the interest in this procedure, and there is now published experience with more than 5,000 procedures globally. This review examines the major controversial aspects of this procedure against the available scientific literature. Surgeons performing this procedure need to be aware of these controversies and counsel their patients appropriately.

Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–52.PubMed

Rutledge R. The mini-gastric bypass: experience with the first 1274 cases. Obes Surg. 2001;11(3):276–80.PubMed

Fisher BL, Buchwald H, Clark W, et al. Mini-gastric bypass controversy. Obes Surg. 2001;11(6):773–7.PubMed

Olchowski S, Timms MR, O’Brien P, et al. More on mini gastric bypass. Obes Surg. 2001;11(4):532.PubMed

Johnson WH, Fernanadez AZ, Farrell TM, et al. Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):37–41.PubMed

Collins BJ, Miyashita T, Schweitzer M, et al. Gastric bypass. Why Roux-en-Y? A review of experimental data. Arch Surg. 2007;142(10):1000–3.PubMed

McCarthy HB, Rucker RD, Chan EK, et al. Gastritis after gastric bypass surgery. Surgery. 1985;98:68–71.PubMed

Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8.PubMed

Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.PubMed

10.

Peraglie C. Laparoscopic mini-gastric bypass (LMGB) in the super-super obese: outcomes in 16 patients. Obes Surg. 2008;18(9):1126–9.PubMed

11.

Chakhtoura G, Zinzindohoué F, Ghanem Y, et al. Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg. 2008;18(9):1130–3.PubMed

12.

Piazza L, Ferrara F, Leanza S, et al. A laparoscopic mini-gastric bypass: short-term single-institute experience. Updates Surg. 2011;63(4):239–42.PubMed

13.

Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.PubMed

14.

García-Caballero M, Valle M, Martínez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with one anastomosis gastric bypass. Nutr Hosp. 2012;27(2):623–31.PubMed

15.

Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg. 2011;35(3):631–6.PubMed

16.

Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22(12):1827–34.PubMed

17.

Sinar DR, Flickinger EG, Park HK, et al. Retrograde endoscopy of the bypassed stomach segment after gastric bypass surgery: unexpected lesions. South Med J. 1985;78(3):255–8.PubMed

18.

Byrne JP, Romagnoli R, Bechi P, et al. Duodenogastric reflux of bile in health: the normal range. Physiol Meas. 1999;20(2):149–58.PubMed

19.

Fuchs KH, Maroske J, Fein M, et al. Variability in the composition of physiologic duodenogastric reflux. J Gastrointest Surg. 1999;3(4):389–95. discussion 395–6.PubMed

20.

Fiorucci S, Distrutti E, Di Matteo F, et al. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol. 1995;90(2):270–6.PubMed

21.

Zhang Y, Yang X, Gu W, et al. Histological features of the gastric mucosa in children with primary bile reflux gastritis. World J Surg Oncol. 2012;10:27.PubMedCentralPubMed

22.

Matsuhisa T, Arakawa T, Watanabe T, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc. 2013;25(5):519–25. doi:10.1111/den.12030.PubMed

23.

Lorusso D, Misciagna G, Mangini V, et al. Duodenogastric reflux of bile acids, gastrin and parietal cells, and gastric acid secretion before and 6 months after cholecystectomy. Am J Surg. 1990;159(6):575–8.PubMed

24.

Kunsch S, Neesse A, Huth J, et al. Increased duodeno-gastro-esophageal reflux (DGER) in symptomatic GERD patients with a history of cholecystectomy. Z Gastroenterol. 2009;47(8):744–8.PubMed

25.

Cabrol J, Navarro X, Simo-Deu J, et al. Evaluation of duodenogastric reflux in gallstone disease before and after simple cholecystectomy. Am J Surg. 1990;160(3):283–6.PubMed

26.

Atak I, Ozdil K, Yücel M, et al. The effect of laparoscopic cholecystectomy on the development of alkaline reflux gastritis and intestinal metaplasia. Hepatogastroenterology. 2012;59(113):59–61.PubMed

27.

Lee Y, Tokunaga A, Tajiri T, et al. Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection. J Gastroenterol. 2004;39(6):520–6.PubMed

28.

Lorusso D, Linsalata M, Pezzolla F, et al. Duodenogastric reflux and gastric mucosal polyamines in the non-operated stomach and in the gastric remnant after Billroth II gastric resection. A role in gastric carcinogenesis? Anticancer Res. 2000;20(3B):2197–201.PubMed

29.

Parrilla P, Lujan JA, Robles R, et al. Duodenogastric reflux quantification in peptic ulcer surgery: comparison between different surgical techniques. Surgery. 1993;113(1):43–7.PubMed

30.

Bechi P, Balzi M, Becciolini A, et al. Gastric cell proliferation kinetics and bile reflux after partial gastrectomy. Am J Gastroenterol. 1991;86(10):1424–32.PubMed

31.

Watson RG, Love AH. Intragastric bile acid concentrations are unrelated to symptoms of flatulent dyspepsia in patients with and without gallbladder disease and postcholecystectomy. Gut. 1987;28(2):131–6.PubMed

32.

Collins BJ, Crothers G, McFarland RJ, et al. Bile acid concentrations in the gastric juice of patients with erosive oesophagitis. Gut. 1985;26(5):495–9.PubMed

33.

Bost R, Hostein J, Valenti M, et al. Is there an abnormal fasting duodenogastric reflux in nonulcer dyspepsia? Dig Dis Sci. 1990;35(2):193–9.PubMed

34.

Schindlbeck NE, Heinrich C, Stellaard F, et al. Healthy controls have as much bile reflux as gastric ulcer patients. Gut. 1987;28(12):1577–83.PubMed

35.

Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20–8.PubMed

36.

Sacks BC, Mattar SG, Qureshi FG, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):11–6.PubMed

37.

Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.PubMed

38.

Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMed

39.

McVay MA, Friedman KE, Applegate KL, et al. Patient predictors of follow-up care attendance in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2012. doi:10.1016/j.soard.2012.11.005.PubMed

40.

Lara MD, Baker MT, Larson CJ, et al. Travel distance, age, and sex as factors in follow-up visit compliance in the post-gastric bypass population. Surg Obes Relat Dis. 2005;1(1):17–21.PubMed

41.

Harper J, Madan AK, Ternovits CA, et al. What happens to patients who do not follow-up after bariatric surgery? Am Surg. 2007;73(2):181–4.PubMed

42.

Shen R, Dugay G, Rajaram K, et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg. 2004;14(4):514–9.PubMed

43.

McQuaid KR, Laine L, Fennerty MB, et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34(2):146–65.PubMed

44.

Nason KS, Farrow DC, Haigh G, et al. Gastric fluid bile concentrations and risk of Barrett’s esophagus. Interact Cardiovasc Thorac Surg. 2007;6(3):304–7.PubMed

45.

Taha AS, Angerson WJ, Morran CG. Reflux and Barrett’s oesophagitis after gastric surgery—long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis. Aliment Pharmacol Ther. 2003;17(4):547–52.PubMed

46.

Parrilla P, Liron R, Martinez de Haro LF, et al. Gastric surgery does not increase the risk of developing Barrett's esophagus. Am J Gastroenterol. 1997;92(6):960–3.PubMed

47.

Avidan B, Sonnenberg A, Schnell TG, et al. Gastric surgery is not a risk for Barrett’s esophagus or esophageal adenocarcinoma. Gastroenterology. 2001;121(6):1281–5.PubMed

48.

Akiyama T, Inamori M, Akimoto K, et al. Gastric surgery is not a risk factor for erosive esophagitis or Barrett’s esophagus. Scand J Gastroenterol. 2010;45(4):403–8.PubMed

49.

Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology. 1994;107(3):747–54.PubMed

50.

Caygill CP, Hill MJ, Kirkham JS, et al. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986;1(8487):929–31.PubMed

51.

Lundegårdh G, Adami HO, Helmick C, et al. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 1988;319(4):195–200.PubMed

52.

Fisher SG, Davis F, Nelson R, et al. A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst. 1993;85(16):1303–10.PubMed

53.

Tersmette AC, Goodman SN, Offerhaus GJ, et al. Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients. Am J Epidemiol. 1991;134(1):14–21.PubMed

54.

Domellöf L, Janunger KG. The risk for gastric carcinoma after partial gastrectomy. Am J Surg. 1977;134(5):581–4.PubMed

55.

Ovaska JT, Havia TV, Kujari HP. Risk of gastric stump carcinoma after gastric resection for benign ulcer disease. Ann Chir Gynaecol. 1986;75(4):192–5.PubMed

56.

Viste A, Bjørnestad E, Opheim P, et al. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet. 1986;2(8505):502–5.PubMed

57.

Schafer LW, Larson DE, Melton 3rd LJ, et al. The risk of gastric carcinoma after surgical treatment for benign ulcer disease. A population-based study in Olmsted County, Minnesota. N Engl J Med. 1983;309(20):1210–3.PubMed

58.

Fischer AB, Graem N, Jensen OM. Risk of gastric cancer after Billroth II resection for duodenal ulcer. Br J Surg. 1983;70(9):552–4.PubMed

59.

Schnapka G, Hofstaedter F, Schwamberger K, et al. Gastric stump carcinoma following Billroth II resection for peptic ulcer disease. Comparison with cancer in non-operated stomach. Endoscopy. 1984;16(5):171–4.PubMed

60.

Pointner R, Schwab G, Königsrainer A, et al. Gastric stump cancer: etiopathological and clinical aspects. Endoscopy. 1989;21(3):115–9.PubMed

61.

Tokudome S, Kono S, Ikeda M, et al. A prospective study on primary gastric stump cancer following partial gastrectomy for benign gastroduodenal diseases. Cancer Res. 1984;44(5):2208–12.PubMed

62.

Luukkonen P, Kalima T, Kivilaakso E. Decreased risk of gastric stump carcinoma after partial gastrectomy supplemented with bile diversion. Hepatogastroenterology. 1990;37 Suppl 2:171–3.PubMed

63.

Kivilaakso E, Hakkiluoto A, Kalima TV, et al. Relative risk of stump cancer following partial gastrectomy. Br J Surg. 1977;64(5):336–8.PubMed

64.

Lagergren J, Lindam A, Mason RM. Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study. Int J Cancer. 2012;131(6):E1048–52.PubMed

65.

La Vecchia C, Negri E, D’Avanzo B, et al. Partial gastrectomy and subsequent gastric cancer risk. J Epidemiol Community Health. 1992;46(1):12–4.PubMed

66.

Lacaine F, Houry S, Huguier M. Stomach cancer after partial gastrectomy for benign ulcer disease. A critical analysis of epidemiological reports. Hepatogastroenterology. 1992;39(1):4–8.PubMed

67.

Hansson LE, Nyrén O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242–9.PubMed

68.

Seoane A, Bessa X, Alameda F, et al. Role of Helicobacter pylori in stomach cancer after partial gastrectomy for benign ulcer disease. Rev Esp Enferm Dig. 2005;97(11):778–85.PubMed

69.

Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–5.PubMed

70.

Marshall BJ, Warren JR, Francis GJ, et al. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol. 1987;82(3):200–10.PubMed

71.

Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988;2(8626–8627):1437–42.PubMed

72.

Tersmette AC, Offerhaus GJ, Tersmette KW, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res. 1990;50(20):6486–9.PubMed

73.

Bahmanyar S, Ye W, Dickman PW, et al. Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer. Am J Gastroenterol. 2007;102(6):1185–91.PubMed

74.

Caygill CP, Knowles RL, Hall R. Increased risk of cancer mortality after vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev. 1991;1(1):35–7.PubMed

75.

Lundegårdh G, Adami HO, Helmick C, et al. Risk of cancer following partial gastrectomy for benign ulcer disease. Br J Surg. 1994;81(8):1164–7.PubMed

76.

Leivonen M, Nordling S, Haglund C. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res. 1997;17(5B):3893–6.PubMed

77.

Nagahata Y, Kawakita N, Azumi Y, et al. Etiological involvement of Helicobacter pylori in “reflux” gastritis after gastrectomy. Am J Gastroenterol. 1996;91(10):2130–4.PubMed

78.

Li XB, Lu H, Chen HM, et al. Role of bile reflux and Helicobacter pylori infection on inflammation of gastric remnant after distal gastrectomy. J Dig Dis. 2008;9(4):208–12.PubMed

79.

Nakagawara H, Miwa K, Nakamura S, et al. Duodenogastric reflux sustains Helicobacter pylori infection in the gastric stump. Scand J Gastroenterol. 2003;38(9):931–7.PubMed

80.

Bair MJ, Wu MS, Chang WH, et al. Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy: correlates with operative procedures and duration after operation. J Formos Med Assoc. 2009;108(1):13–9.PubMed

81.

Tomtitchong P, Onda M, Matsukura N, et al. Helicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomoses. J Clin Gastroenterol. 1998;27 Suppl 1:S154–8.PubMed

82.

Sitarz R, Maciejewski R, Polkowski WP, et al. Gastroenterostoma after Billroth antrectomy as a premalignant condition. World J Gastroenterol. 2012;18(25):3201–6.PubMed

83.

Nunobe S, Ohyama S, Miyata S, et al. Incidence of gastric cancer in the remnant stomach after proximal gastrectomy. Hepatogastroenterology. 2008;55(86–87):1855–8.PubMed

84.

Tersmette AC, Giardiello FM, Offerhaus GJ, et al. Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res. 1991;82(3):266–72.PubMed

85.

Lee SW, Tanigawa N, Nomura E, et al. Benefits of intracorporeal gastrointestinal anastomosis following laparoscopic distal gastrectomy. World J Surg Oncol. 2012;10:267.PubMedCentralPubMed

86.

Du J, Shuang J, Li J, et al. Totally laparoscopic Billroth II gastrectomy with a novel, safe, simple, and time-saving anastomosis by only stapling devices. J Gastrointest Surg. 2012;16(4):738–43.PubMed

87.

Lee J, Kim D, Kim W. Comparison of laparoscopy-assisted and totally laparoscopic Billroth-II distal gastrectomy for gastric cancer. J Korean Surg Soc. 2012;82(3):135–42.PubMedCentralPubMed

88.

Oh SJ, Hong JJ, Oh CA, et al. Stapling technique for performing Billroth II anastomosis after distal gastrectomy. J Gastrointest Surg. 2011;15(7):1244–6.PubMed

89.

Kang KC, Cho GS, Han SU, et al. Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group. Comparison of Billroth I and Billroth II reconstructions after laparoscopy-assisted distal gastrectomy: a retrospective analysis of large-scale multicenter results from Korea. Surg Endosc. 2011;25(6):1953–61.PubMed

90.

Sah BK, Chen MM, Yan M, et al. Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy? BMC Cancer. 2009;9:428.PubMedCentralPubMed

91.

Lagergren J, Lindam A. The risk of oesophageal adenocarcinoma after gastrectomy for peptic ulcer disease. Eur J Cancer. 2012;48(5):749–52.PubMed

92.

Birgisson S, Rice TW, Easley KA, et al. The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study. Am J Gastroenterol. 1997;92(2):216–21.PubMed

93.

Alexandrou A, Davis PA, Law S, et al. Esophageal cancer in patients with a history of distal gastrectomy. Arch Surg. 2002;137(11):1238–42.PubMed

94.

Hashimoto N, Inayama M, Fujishima M, et al. Esophageal cancer after distal gastrectomy. Dis Esophagus. 2006;19(5):346–9.PubMed

95.

Lorusso D, Pezzolla F, Linsalata M, et al. Duodenogastric reflux and gastric mucosal cell proliferation after cholecystectomy or Billroth II gastric resection. Gastroenterol Clin Biol. 1994;18(11):927–31.PubMed

96.

Wilson P, Jamieson JR, Hinder RA, et al. Pathologic duodenogastric reflux associated with persistence of symptoms after cholecystectomy. Surgery. 1995;117(4):421–8.PubMed

97.

Fein M, Bueter M, Sailer M, et al. Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms. Dig Dis Sci. 2008;53(5):1186–91.PubMed

98.

Fall K, Ye W, Nyrén O. Risk for gastric cancer after cholecystectomy. Am J Gastroenterol. 2007;102(6):1180–4.PubMed

99.

Freedman J, Lagergren J, Bergström R, et al. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg. 2000;87(8):1087–93.PubMed

100.

Ge Z, Zhao C, Wang Y, et al. Cholecystectomy and the risk of esophageal and gastric cancer. Saudi Med J. 2012;33(10):1073–9.PubMed

101.

Gustavsson S, Adami HO, Meirik O, et al. Cholecystectomy as a risk factor for gastric cancer. A cohort study. Dig Dis Sci. 1984;29(2):116–20.PubMed

102.

Freedman J, Ye W, Näslund E, et al. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121(3):548–53.PubMed

103.

Lagergren J, Mattsson F. Cholecystectomy as a risk factor for oesophageal adenocarcinoma. Br J Surg. 2011;98(8):1133–7.PubMed

104.

Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.PubMed

105.

Inoue H, Rubino F, Shimada Y, et al. Risk of gastric cancer after Roux-en-Y gastric bypass. Arch Surg. 2007;142(10):947–53.PubMed

106.

Rutledge R. Hospitalization before and after mini-gastric bypass surgery. Int J Surg. 2007;5(1):35–40.PubMed

107.

Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15(5):648–54.PubMed

108.

Noun R, Zeidan S. Laparoscopic mini-gastric bypass: an effective option for the treatment of morbid obesity. J Chir (Paris). 2007;144(4):301–4 [Article in French].

109.

Chevallier JM, Chakhtoura G, Zinzindohoué F. [Laparoscopic mini-gastric bypass]. J Chir (Paris). 2009;146(1):60–4.

110.

Copăescu C, Munteanu R, Prala N, et al. Laparoscopic mini gastric bypass for the treatment of morbid obesity. Initial experience. Chirurgia (Bucur). 2004;99(6):529–39 [Article in Romanian].

111.

Hu XG, Zheng CZ, Ji XR, et al. Short-term outcome of laparoscopic gastric bypass and minigastric bypass on obesity patients with type 2 diabetes mellitus. Zhonghua Wei Chang Wai Ke Za Zhi. 2009;12(6):554–7 [Article in Chinese].PubMed

112.

Guo X, Yin K, Zhuo GZ, et al. Efficacy comparison between 2 methods of laparoscopic gastric bypass surgery in the treatment of type 2 diabetes mellitus]. Zhonghua Wei Chang Wai Ke Za Zhi. 2012;15(11):1125–8 [Article in Chinese].PubMed

113.

Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis. 2011;7(4):486–91.PubMed

114.

Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.PubMed

115.

Lee WJ, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18(3):294–9.PubMed

116.

Noun R, Riachi E, Zeidan S, et al. Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2007;17(11):1482–6.PubMed

117.

Mahawar KK, Jennings N, Brown J, Gupta A, Balupuri S, Small PK. “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg. 2003.

118.

Kuzmak LI, Yap IS, McGuire L, et al. Surgery for morbid obesity. Using an inflatable gastric band. AORN J. 1990;51(5):1307–24. Erratum in: AORN J 1990; 51(6): 1573.PubMed

119.

de Csepel J, Burpee S, Jossart G, et al. Laparoscopic biliopancreatic diversion with a duodenal switch for morbid obesity: a feasibility study in pigs. J Laparoendosc Adv Surg Tech A. 2001;11(2):79–83.PubMed

120.

Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50). Obes Surg. 2005;15(5):612–7.PubMed

121.

Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19(12):1605–11.PubMed

122.

Lomanto D, Lee WJ, Goel R, et al. Bariatric surgery in Asia in the last 5 years (2005–2009). Obes Surg. 2012;22(3):502–6. Erratum in: Obes Surg. 2012 Feb;22(2):345. Fah, Chin Kin [corrected to Chin, Kin-Fah].PubMed

123.

Himpens J, Cadière GB, Bazi M, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg. 2011;146(7):802–7.PubMed

124.

Stroh C, Hohmann U, Schramm H, et al. Fourteen-year long-term results after gastric banding. J Obes. 2011;2011:128451.PubMedCentralPubMed

125.

Weiner RA, Theodoridou S, Weiner S. Failure of laparoscopic sleeve gastrectomy—further procedure? Obes Facts. 2011;4 Suppl 1:42–6.PubMed

126.

Gautier T, Sarcher T, Contival N, et al. Indications and mid-term results of conversion from sleeve gastrectomy to Roux-en-Y gastric bypass. Obes Surg. 2013;23(2):212–5.PubMed

127.

Chiu S, Birch DW, Shi X, et al. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011;7(4):510–5.PubMed

128.

Azagury DE, Varban O, Tavakkolizadeh A, et al. Does laparoscopic gastric banding create hiatal hernias? Surg Obes Relat Dis. 2013;9(1):48–52.PubMed

Titel: Controversy Surrounding ‘Mini’ Gastric Bypass
verfasst von: Kamal K. Mahawar
William R. J. Carr
Shlok Balupuri
Peter K. Small
Publikationsdatum: 01.02.2014
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 2/2014
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-013-1090-0

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Development of Ulcer Disease After Roux-en-Y Gastric Bypass, Incidence, Risk Factors, and Patient Presentation: A Systematic Review

Changes in Intestinal Permeability after Roux-en-Y Gastric Bypass

Patients' Perspectives on Laparoscopic Adjustable Gastric Banding (LAGB) Aftercare Attendance: Qualitative Assessment

Association Between Liver Vitamin A Reserves and Severity of Nonalcoholic Fatty Liver Disease in the Class III Obese Following Bariatric Surgery

Excess Body Weight Loss is Associated with Nonpathological Gait Patterns in Women 4 to 5 Years After Bariatric Surgery

Long-Term Results of a Prospective Comparison of Roux-en-Y Gastric Bypass versus a Variant of Biliopancreatic Diversion in a Non-Superobese Population (BMI 35–50 kg/m2)

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“